|
Novartis recognized among world's most sustainable companies in Corporate Knights Global 100
|
28 January 2014 |
|
Novartis Africa Day highlights company's efforts to expand access to healthcare
|
06 December 2013 |
|
Novartis Foundation launches new leprosy strategy at symposium on disease elimination
|
29 November 2013 |
|
Novartis highlights growth prospects driven by significant R&D pipeline progress and the expected increase in blockbuster treatments
|
25 November 2013 |
|
Novartis announces positive clinical trial results for novel H7N9 vaccine
|
14 November 2013 |
|
Novartis delivers strong sales performance in third quarter
|
22 October 2013 |
|
Novartis launches fully interactive Facebook ‘Retina App’ on World Sight Day to raise awareness of retinal disease
|
10 October 2013 |
|
Secukinumab (AIN457) showed superiority over Enbrel®
|
04 October 2013 |
|
Malaria No More and Novartis launch Power of One, a global digital fundraising campaign to help eliminate malaria deaths
|
23 September 2013 |
|
Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free
|
19 September 2013 |